CDMO R&D Innovation & Proprietary Platforms Improve Speed To Market And Quality For Protein Biologics

AGC Biologics, a global CDMO that harnesses its R&D centers to bring modern and efficient approaches to development and manufacturing. The company’s R&D centers work alongside its teams at its seven global sites to create strategies and procedures that emphasize quality product delivery.

Through the work of its research and development scientists AGC Biologics is creating innovations and offering the latest technology for early and late stage clients, helping them focus on increasing mass, increased speed to market, and overall process intensification.